Hims & Hers shares rise as company adds new weight-loss medications to platform

Source: CNBC | Published: April 1, 2025, 11:32 p.m.

Hims & Hers is adding Zepbound, Mounjaro, and the generic injection liraglutide to its platform.

Read Original Article Back to News List

Related News

Jim Cramer says Trump tariffs are more punitive than reciprocal

1 hour, 51 minutes ago

Advertisers look for flexibility as they parse how Trump's new tariffs will affect their businesses

2 hours, 26 minutes ago

The most powerful passports of 2025 — a new country tops the list

2 hours, 33 minutes ago

Treasury Secretary Bessent says market woes are more about tech stock sell-off than Trump's tariffs

2 hours, 45 minutes ago

Apple leads a drop in tech stocks after Trump tariff announcement

3 hours, 13 minutes ago